Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLATIRAMER for Multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 27,144 adverse event reports in the FDA FAERS database where GLATIRAMER was used for Multiple sclerosis.

Most Reported Side Effects for GLATIRAMER

Side Effect Reports % Deaths Hosp.
Injection site pain 5,003 10.8% 2 181
Multiple sclerosis relapse 3,695 8.0% 6 718
Drug ineffective 3,321 7.2% 4 168
Injection site reaction 3,317 7.2% 6 95
Multiple sclerosis 2,596 5.6% 22 240
Injection site erythema 2,560 5.5% 2 120
Fatigue 2,408 5.2% 2 273
Dyspnoea 2,364 5.1% 6 366
Injection site mass 2,172 4.7% 0 92
Injection site swelling 1,836 4.0% 1 91
Fall 1,701 3.7% 7 501
Injection site pruritus 1,579 3.4% 0 64
Pain 1,529 3.3% 1 196
Urticaria 1,366 3.0% 1 94
Dizziness 1,349 2.9% 1 215

Other Indications for GLATIRAMER

Product used for unknown indication (6,140) Relapsing-remitting multiple sclerosis (1,965) Relapsing multiple sclerosis (375) Multiple sclerosis relapse (133) Secondary progressive multiple sclerosis (63) Clinically isolated syndrome (59) Primary progressive multiple sclerosis (30) Progressive multiple sclerosis (21) Rheumatoid arthritis (11) Multiple sclerosis relapse prophylaxis (10)

Other Drugs Used for Multiple sclerosis

DIMETHYL (78,567) NATALIZUMAB (56,733) INTERFERON BETA-1A (56,475) FINGOLIMOD (43,123) TERIFLUNOMIDE (29,963) DALFAMPRIDINE (28,787) OCRELIZUMAB (15,501) OFATUMUMAB (11,816) PEGINTERFERON BETA-1A (11,105) DIROXIMEL (9,977)

Related Pages

GLATIRAMER Full Profile All Multiple sclerosis Drugs GLATIRAMER Demographics GLATIRAMER Timeline